Understanding displacement of onboard contingents in Navy amphibious ships

Heitor Martinez-Grueira; Rafael Asorey-Cacheda; Antonio-Javier Garcia-Sanchez; Joan Garcia-Haro

doi:10.1371/journal.pone.0316266

Peer Review History

Original SubmissionOctober 20, 2023
12 Nov 2024 Decision Letter - Chun Kai Leung, Editor PONE-D-23-34444Understanding displacement of onboard contingents in Navy amphibious shipsPLOS ONE Dear Dr. Asorey-Cacheda, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 27 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Chun Kai Leung, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data). 3. Thank you for stating the following financial disclosure: [This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Please expand the acronym “AEI” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 6. Thank you for stating the following in your Competing Interests section: [NO authors have competing interests]. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 7. Please upload a copy of Supporting Information Figure/Table/etc. S1 Appendix. Normality tests which you refer to in your text on page 13. 8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ******** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ****** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ****** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ****** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Excellent summary of a complex and important study. The supporting documentation and detailed method section with additional images and tables provide background to the project. There is nothing I would change, but more background and more literature review for those not as versed in this area may help. Reviewer #2: The manuscript is well written and I have some minor suggestions before the manuscript is good to go. 1. Please make the underlying dataset available - this is PLOS ONE's policy unless there is an justification (e.g., privacy, national security information) for not releasing the dataset publicly. 2. Line 52, "Finally, Section “Conclusions” concludes", this phrase seems a bit weird. Can you rephrase it? 3. Have you got an ethical approval or at least an informed consent? PLOS ONE is very strict about this. Do mention it in your methodology or refer to the guidelines for authors. 4. Can you provide a descriptive statistics of your research participants' demographics , such as age, gender, BMI, or seniority, etc. 5. Can you be more specific about the policy implications? Perhaps you can suggest what policy should relevant legal authorities should enact in light of your results (One paragraph). Overall a good job. If you cannot address some of the comments, please let me know why. ****** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Bradley Wade Bishop Reviewer #2: No ******** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. https://doi.org/10.1371/journal.pone.0316266.r001
Revision 1
21 Nov 2024 Author Response Response to editors: 3. Thank you for stating the following financial disclosure: [This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.]. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. Due to the time that has passed since the paper submission, the financial disclosure has changed. Additionally, as any of funder had any role, we have added "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." to the financial information: This work was a result of the ThinkInAzul and AgroAlNext programmes, funded by Ministerio de Ciencia, Innovación y Universidades (MICIU) with funding from European Union NextGenerationEU/PRTR-C17.I1 and by Fundación Séneca with funding from Comunidad Autónoma Región de Murcia (CARM). This work was also supported by the grants PID2023-148214OB-C21 and TED2021-129336B-I00, funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. This work was also funded by Fundación Séneca (22236/PDC/23). This research was also contextualized to DAIMon, a cascade funding action deriving from the Horizon Europe project aerOS, funded by the European Commission under grant number 101069732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 4. Please expand the acronym “AEI” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. AEI states for “Agencia Estatal de Investigación”. The reason of only using the acronym is because it is how it is stated by AEI 5. Thank you for stating the following in the Acknowledgments Section of your manuscript: This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [This work was supported by the grants PID2020-116329GB-C22 and TED2021-129336B-I00 funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.] Please include your amended statements within your cover letter; we will change the online submission form on your behalf. This is the funding statement we want to be included: This work was a result of the ThinkInAzul and AgroAlNext programmes, funded by Ministerio de Ciencia, Innovación y Universidades (MICIU) with funding from European Union NextGenerationEU/PRTR-C17.I1 and by Fundación Séneca with funding from Comunidad Autónoma Región de Murcia (CARM). This work was also supported by the grants PID2023-148214OB-C21 and TED2021-129336B-I00, funded by MICIU/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. This work was also funded by Fundación Séneca (22236/PDC/23). This research was also contextualized to DAIMon, a cascade funding action deriving from the Horizon Europe project aerOS, funded by the European Commission under grant number 101069732. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 6. Thank you for stating the following in your Competing Interests section: [NO authors have competing interests]. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. Please, indicate the following in the online submission form: NO authors have competing interests. 7. Please upload a copy of Supporting Information Figure/Table/etc. S1 Appendix. Normality tests which you refer to in your text on page 13. The Appendix “Normality tests” does not use supporting information. This appendix is introduced to explain the calculation method for this type of test, which is one of those used for the study presented in this article. 8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. The reference list has been checked. Regarding retracted paper, we have not found any in the reference list. Response to reviewers: 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No Unfortunately, we cannot disclose the data sets used for this study. Since the data used to carry out this displacement study have been extracted from a range of tests carried out by military personnel on board a Spanish Navy ship, these data are the property of the General Staff of the Navy (EMA) and, ultimately, of the Spanish State. It is also possible to use such data for the performance of a duly motivated and justified research, being mandatory to obtain an official authorization that enables the collection and processing of such data. This authorization will be issued by the owner of the data, in this particular case, by the EMA. 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Excellent summary of a complex and important study. The supporting documentation and detailed method section with additional images and tables provide background to the project. There is nothing I would change, but more background and more literature review for those not as versed in this area may help. Thanks for your comments. We do really appreciate them. Reviewer #2: The manuscript is well written and I have some minor suggestions before the manuscript is good to go. 1. Please make the underlying dataset available - this is PLOS ONE's policy unless there is an justification (e.g., privacy, national security information) for not releasing the dataset publicly. Since the data used to carry out this displacement study have been extracted from a range of tests carried out by military personnel on board a Spanish Navy ship, these data are the property of the General Staff of the Navy (EMA) and, ultimately, of the Spanish State. It is also possible to use such data for the performance of a duly motivated and justified research, being mandatory to obtain an official authorization that enables the collection and processing of such data. This authorization will be issued by the owner of the data, in this particular case, by the EMA. 2. Line 52, "Finally, Section “Conclusions” concludes", this phrase seems a bit weird. Can you rephrase it? The phrase has been rewritten as: Finally, Section “Conclusions” provides the closing remarks. 3. Have you got an ethical approval or at least an informed consent? PLOS ONE is very strict about this. Do mention it in your methodology or refer to the guidelines for authors. Yes, all study participants were military personnel and provided informed consent. Moreover, we have modified the fourth paragraph of Section “Material and methods”, line 70, page 2, as follows: To conduct the range of tests, the Spanish Navy was asked to designate the amphibious assault ship “Galicia” (L-51) as the study vessel during the course of regular national maneuvers in the Gulf of Cadiz and all participating military personnel provided informed consent. This type of ship was used since the platform's and its personnel's characteristics needed to match the planned research. This would be challenging due to the vessel's dimensions, the size of the reference population, and the heterogeneity of the personnel on board. 4. Can you provide a descriptive statistics of your research participants' demographics , such as age, gender, BMI, or seniority, etc. This information is provided throughout the manuscript. Tables 1 and 2 describe the relevant demographic characteristics of the control groups. Thus, 10 control groups with members belonging to the demographic groups described in Tables 1, 2, and 6 were used for the study. Tables 3, 4, 5, 7, 8 and 9 show the values obtained for each of these groups (y0 to y9), while each row represents an individual belonging to one of the demographic groups. In this sense, to facilitate the interpretation of these tables (3, 4, 5, 7, 8, 9), we have chosen to add a new column on the left with the ID corresponding to the demographic factors in tables 1, 2 and 6. 5. Can you be more specific about the policy implications? Perhaps you can suggest what policy should relevant legal authorities should enact in light of your results (One paragraph). Thanks for the suggestion. We have added the following paragraph at the end of the Section “Conclusions” (page 14, line 363): Considering the study's findings, it is recommended that relevant jurisdictions adopt policies that promote data-driven approaches to decision making. Thus, ship evacuation plans should take into consideration and adjust to the demographic characteristics of the embarked population. In particular, these authorities should mandate regular data collection and validation to ensure the accuracy and relevance of data sets used in policy planning and plan development. Overall a good job. If you cannot address some of the comments, please let me know why. Thanks for this comment. We think we have addressed all of your comments, but the one regarding data availability due to security constraints. Attachments Attachment Submitted filename: Response to reviewers.docx https://doi.org/10.1371/journal.pone.0316266.r002
9 Dec 2024 Decision Letter - Chun Kai Leung, Editor Understanding displacement of onboard contingents in Navy amphibious ships PONE-D-23-34444R1 Dear Dr. Asorey-Cacheda, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chun Kai Leung, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: https://doi.org/10.1371/journal.pone.0316266.r003
Formally Accepted
18 Dec 2024 Acceptance Letter - Chun Kai Leung, Editor PONE-D-23-34444R1 PLOS ONE Dear Dr. Asorey-Cacheda, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Chun Kai Leung Academic Editor PLOS ONE https://doi.org/10.1371/journal.pone.0316266.r004

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .